Faculty profile
Éric Berthelet
Back to facultyResearch
Read how they describe their research on their Université de Montréal profile.
Latest funding
- $100,000
A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
CIHR · 2017 · Co-investigator
No publications available.
A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
Principal investigators: Parulekar, Wendy R; Bratman, Scott V
Keywords: Cooperative Group; De-Escalation; Head And Neck Cancer; Human Papillomavirus; Multi-Institutional; Oropharynx Cancer; Phase Ii Clinical Study; Radiotherapy
From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.